Document Classification

Section Type: METHODS

Text: Patients received either continuous venous infusion (CVI) of 5-Fluorouracil (5-FU), 225 mg/m (2) per day, 7 days per week plus pelvic hyperfractionated radiation (HRT), 45. 6 Gy at 1. 2 Gy twice daily plus a boost of 9. 6 to 14. 4 Gy for T3 or T4 cancers (Arm 1), or CVI of 5-FU, 225 mg/m (2) per day, Monday to Friday, plus irinotecan, 50 mg/m (2) once weekly 4, plus pelvic radiation therapy (RT), 45 Gy at 1. 8 Gy per day and a boost of 5. 4 Gy for T3 and 9 Gy for T4 cancers (Arm 2).